Natural course of persistent hepatitis B virus infection in hepatitis B e antigen-positive and hepatitis B e antigen-negative cohorts in Japan based on the Markov model

被引:5
作者
Yamasaki, Kazumi [1 ]
Tanaka, Junko [2 ]
Kurisu, Akemi [2 ]
Akita, Tomoyuki [2 ]
Ohisa, Masayuki [2 ]
Sakamune, Kazuaki [2 ]
Ko, Ko [2 ]
Sugiyama, Aya [2 ]
Yasaka, Takahiro [3 ]
Shirahama, Satoshi [3 ]
机构
[1] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan
[2] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan
[3] Kamigoto Hosp, Nagasaki, Japan
关键词
cumulative incidence; hepatitis B e antigen; Markov model; persistent Hepatitis B virus infection; transition probability; NUCLEOTIDE-SEQUENCE; SURFACE-ANTIGEN; IMMUNOPROPHYLAXIS;
D O I
10.1002/jmv.25260
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Highlights1.2.3. This population-based study examined the natural course of hepatitis B e antigen (HBeAg)-positive or HBeAg-negative persistent hepatitis B virus (HBV) infection, adjusted by age and liver disease states using a Markov model. Using 12 417 person-years data (n=862), annual transition probabilities were estimated, and age-adjusted cumulative incidence and natural history of persistent HBV infection were simulated in both sexes of groups 1 (HBeAg-negative status with HBV DNA level <4.0logIU/mL at entry) and 2 (persistent HBeAg-positive status throughout the study). In group 1, 15.26% of 30-years old men with chronic hepatitis (CH) were expected to remain in the same state at age 65 years, 28.32% subsided into an hepatitis B surface antigen (HBsAg)-negative state, and 13.20% developed hepatocellular carcinoma (HCC). The expectations for 40-years old men in group 1 were 21.43%, 19.86%, and 15.04%, respectively. The expectations for 30 years women in group 1 were 30.57%, 21.15%, and 4.08%, respectively. These results suggest that HBeAg positivity caused a higher risk of HCC onset in persistent HBV infection after adjustments for age, sex, and liver disease state. HCC was likely to develop, but unlikely to subside into HBsAg clearance, remaining in a CH state with aging, regardless of HBeAg state. Furthermore, both HCC development and HBsAg clearance occurred more frequently in men than in women, irrespective of HBeAg status. HBeAg-positive state per se is one of the risk factor for severe liver complications. The rate of HBsAg clearance was higher in males than in females. Markov model is useful to simulate the age-matched survival rate or cumulative incidence using 1-year transition probability.
引用
收藏
页码:1800 / 1813
页数:14
相关论文
共 18 条
[1]   JS']JSH Guidelines for the Management of Hepatitis B Virus Infection [J].
Asahina, Yasuhiro ;
Hayashi, Norio ;
Hiramatsu, Naoki ;
Izumi, Namiki ;
Koike, Kazuhiko ;
Kumada, Hiromitsu ;
Kurosaki, Masayuki ;
Oketani, Makoto ;
Suzuki, Fumitaka ;
Takikawa, Hajime ;
Tanaka, Atsushi ;
Tanaka, Eiji ;
Tanaka, Yasuhito ;
Tsubouchi, Hirohito ;
Yotsuyanagi, Hiroshi .
HEPATOLOGY RESEARCH, 2014, 44 :1-58
[2]  
Blumberg BS, JAMA, V191, P541
[3]   Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion [J].
Chu, C. -M. ;
Liaw, Y. -F. .
JOURNAL OF VIRAL HEPATITIS, 2007, 14 (03) :147-152
[4]  
DANE DS, 1970, LANCET, V1, P695
[5]   NUCLEOTIDE-SEQUENCE OF THE HEPATITIS-B VIRUS GENOME (SUBTYPE AYW) CLONED IN ESCHERICHIA-COLI [J].
GALIBERT, F ;
MANDART, E ;
FITOUSSI, F ;
TIOLLAIS, P ;
CHARNAY, P .
NATURE, 1979, 281 (5733) :646-650
[6]   Hepatitis B e antigen-negative chronic hepatitis B: Natural history and treatment [J].
Hadziyannis, SJ ;
Papatheodoridis, GV .
SEMINARS IN LIVER DISEASE, 2006, 26 (02) :130-141
[7]   Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981-1992) and epidemiological evidence for its efficacy [J].
Koyama, T ;
Matsuda, I ;
Sato, S ;
Yoshizawa, H .
HEPATOLOGY RESEARCH, 2003, 26 (04) :287-292
[8]  
Koyama T, 2007, PERSP MED V, V13, P141, DOI 10.1016/S0168-7069(06)13008-6
[9]   Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3 [J].
Liakina, V. ;
Hamid, S. ;
Tanaka, J. ;
Olafsson, S. ;
Sharara, A. I. ;
Alavian, S. M. ;
Gheorghe, L. ;
El Hassan, E. S. ;
Abaalkhail, F. ;
Abbas, Z. ;
Abdou, A. ;
Abourached, A. ;
Al Braiki, F. ;
Al Hosani, F. ;
Al Jaberi, K. ;
Al Khatry, M. ;
Al Mulla, M. A. ;
Al Quraishi, H. ;
Al Rifai, A. ;
Al Serkal, Y. ;
Alam, A. ;
Alashgar, H. I. ;
Alawadhi, S. ;
Al-Dabal, L. ;
Aldins, P. ;
Alfaleh, F. Z. ;
Alghamdi, A. S. ;
Al-Hakeem, R. ;
Aljumah, A. A. ;
Almessabi, A. ;
Alqutub, A. N. ;
Alswat, K. A. ;
Altraif, I. ;
Alzaabi, M. ;
Andrea, N. ;
Assiri, A. M. ;
Babatin, M. A. ;
Baqir, A. ;
Barakat, M. T. ;
Bergmann, O. M. ;
Bizri, A. R. ;
Blach, S. ;
Chaudhry, A. ;
Choi, M. S. ;
Diab, T. ;
Djauzi, S. ;
El Khoury, S. ;
Estes, C. ;
Fakhry, S. ;
Farooqi, J. I. .
JOURNAL OF VIRAL HEPATITIS, 2015, 22 :4-20
[10]   THE DEVELOPMENT OF CIRRHOSIS IN PATIENTS WITH CHRONIC TYPE-B HEPATITIS - A PROSPECTIVE-STUDY [J].
LIAW, YF ;
TAI, DI ;
CHU, CM ;
CHEN, TJ .
HEPATOLOGY, 1988, 8 (03) :493-496